Regarding E2F6, the expression was observed to be down-regulated in PCa compared to benign tissues (benign vs. cancer = 1.85 ± 0.03 vs. 1.78 ± 0.01, p < 0.05). The gene discussed is E2F6; the disease is posterior cortical atrophy.